New Key Statistics Module, Z-Score and F-Score
NAS:BBIO Key Ratios
| Market Cap $ M | 4,892.61 |
| Enterprise Value $ M | 6,174.12 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 21.19 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 219.00 |
| EPS (TTM) $ | -2.63 |
| Beneish M-Score | 29.75 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -9.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -16.57 |
| EV-to-EBITDA | -16.86 |
| PEG | -- |
| Shares Outstanding M | 188.03 |
| Net Margin (%) | -207.11 |
| Operating Margin % | -229.54 |
| Pre-tax Margin (%) | -210.62 |
| Quick Ratio | 4.59 |
| Current Ratio | 4.59 |
| ROA % (ttm) | -67.76 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -293.21 |
| Dividend Yield % | -- |
| Altman Z-Score | -3.69 |
BBIO Number of Guru Trades
BBIO Volume of Guru Trades
Gurus Latest Trades with NAS:BBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BBIO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BridgeBio Pharma Inc Insider Transactions
No Available Data
News about NAS:BBIO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers